STTK Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 1.69%, SMA50 2.85%, SMA200 90.68%). The stock’s 14-day RSI is 51.25 (neutral), while the ATR of 0.31 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.38% below its high and over 483.69% above its low. Average 10-day trading volume of 754.29 thousand shares is below the 3-month average of 1.27 million, indicating normal recent market interest.

Shattuck Labs, Inc. has 100.36 million shares outstanding. The public float is 67.76 million shares, elevated short interest at 6.58% of float. This equals 6.39 million shares. The short ratio is 4.87 days. Institutional investors hold 83.5% of the float. Insiders own 4.08%. Redmile Group, LLC holds 5.41 million shares, Ashiya Mona has 5.30 million shares and ORBIMED ADVISORS LLC has 5.30 million shares. Over the past six months, insider transactions show net selling. They sold 53.88 thousand shares across 4 transactions.

Shattuck Labs, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.46. This means the shares are trading above this model’s fair value.

Shattuck Labs, Inc. generated EPS of -$1.02 over the past year. Five-year average earnings growth is -20.93%. Wall Street analysts project EPS growth of 32.63% annually over the next five years. The latest quarter delivered EPS of -$0.12. The next quarter is forecast at -$0.14. Next year's EPS is expected at $13.28. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 6 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $18.00 to $4.00. The high target offers 184.36% upside. The low target suggests -36.81% downside. The mean target is $12.36. This offers 95.26% upside. Shattuck Labs, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended August 11, 2026, missed forecasts by -3.28%. The prior quarter beat by -7.14%. Over the last six quarters, Apple has recorded several small beats. These include -6.9% in May 01, 2025.

Shattuck Labs, Inc. (NASDAQ:STTK) closed at $6.33 USD, losing -$0.17 (-2.62%) from the previous close of $6.50. The stock is currently mid-range between its 52-week high and low $1.68 and $8.33. With a market capitalization of about $572.06 million, Shattuck Labs, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.10). Key stats such as the average daily volume over the past year has been around 1.27 million shares, in line with its 52-week average. Headquartered in Austin, TX, Shattuck Labs, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Taylor H. Schreiber, the company employs approximately 40 people and listed since October 09, 2020. Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage.

Shattuck Labs, Inc. trades at a P/E ratio of -12.33, slightly below the S&P 500 average, with a price-to-sales ratio of 568.44 and a price-to-book ratio of 3.87 trading at moderately above to book value. The P/FCF stands at -13.78, also below market averages.

Shattuck Labs, Inc. (NASDAQ:STTK) shares are up 18.9% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Shattuck Labs, Inc. trading at a premium to the broader market with a P/E of -12.33. Analyst sentiment is cautious, with the majority of ratings in Strong Buy territory and a mean price target of $15.05, suggesting 137.76% upside. Our AI forecast model points to short-term weakness (-10.58% over two weeks), a medium-term rise (85.15% over three months), and a longer-term gain (236.65% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Shattuck Labs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -10.58%, with price expected at $5.66 by September 23, 2026, within a range of $5.33 to $5.99 3-Month Outlook: Projected rise of 85.15%, reaching $11.72 by December 07, 2026, with a range of $11.61 to $11.83. 1-Year Outlook: Projected gain of 236.65%, with price at $21.31 by September 09, 2027, within a range of $23.05 to $24.17.